Molina Healthcare, US60855R1005

Wall Street Zen downgrades Molina Healthcare stock to Sell

Published on 10/05/2026 at 17:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter diluted earnings fell to USD 1.19 from USD 4.75. Molina Healthcare stock costs EUR 170.48 on October 5, 2026 versus EUR 168.45.

Farbiges Comicbild eines Arztes und einer Krankenschwester mit Patient in heller Klinik
Pop-Art-Comic illustriert Molina Healthcare US60855R1005 mit freundlichem Arzt und Pflegekraft in einer hellen Klinikszene, Illustration mit AI erstellt.

Molina Healthcare (ISIN US60855R1005) stock was trading at EUR 170.48 at Lang & Schwarz on October 5, 2026 at 5:03 p.m. CEST, up 1.21 percent versus the prior close of EUR 168.45. The immediate catalyst is a rating downgrade ahead of the company's next quarterly report.

Sell rating arrives before results

According to MarketBeat on October 4, 2026, Wall Street Zen downgraded Molina Healthcare from Hold to Sell. MarketBeat also reported an average analyst price target of USD 202.44, with three Buy, eleven Hold and two Sell ratings in its cited analyst group.

Second-quarter earnings weakened

Molina's second-quarter 2026 filing showed total revenue of USD 10.87 billion, net income of USD 60.0 million and diluted earnings per share of USD 1.19. According to MarketWatch, net income was USD 255.0 million and diluted earnings per share were USD 4.75 in the second quarter of 2025. Premium revenue fell 6.00 percent year over year to USD 10.24 billion, while the medical care ratio rose to 92.20 percent from 90.40 percent.

October report sets next test

Moomoo reported that Molina maintained full-year 2026 premium revenue guidance of USD 42.00 billion and raised adjusted earnings guidance to at least USD 5.25 per share in its second-quarter update. The same update identified a USD 1.50 per-share Florida Medicaid headwind in the fourth quarter and a USD 1.00 per-share impact from the traditional Medicare Advantage business planned for exit in 2027.

TradingView lists October 21, 2026 as the next earnings date and identifies Molina Healthcare under ticker MOH on the New York Stock Exchange.

Stock stays below its yearly high

Molina Healthcare's market capitalization was USD 10.0 billion as of October 5, 2026. Its primary-exchange 52-week range was USD 121.06 to USD 244.89, leaving the current market value below the upper end of that interval while the euro quote gained 1.21 percent against the Lang & Schwarz prior close.

At Lang & Schwarz, Molina Healthcare stock was trading at EUR 170.48 on October 5, 2026 at 5:03 p.m. CEST, compared with the prior close of EUR 168.45 on October 2, 2026. The further course of trading is shown by the continuously updated real-time quote of Molina Healthcare stock.

Molina Healthcare market data

  • Company: Molina Healthcare, Inc.
  • ISIN: US60855R1005
  • Ticker: MOH
  • Primary exchange: New York Stock Exchange
  • Price Lang & Schwarz (as of October 5, 2026, 5:03 p.m. CEST): EUR 170.48
  • Change versus prior close: plus 1.21 percent
  • Prior close Lang & Schwarz (October 2, 2026): EUR 168.45
  • Market capitalization: USD 10.0 billion (as of October 5, 2026)
  • 52-week range: USD 121.06-244.89 (as of October 5, 2026)
  • Sector / Industry: Healthcare / Medical - Healthcare Plans

More news and analyses on Molina Healthcare stock

Disclaimer...

en | US60855R1005 | MOLINA HEALTHCARE | boerse | 70234213 | bgmi